Predicting survival in metastatic non-small cell lung cancer patients with poor ECOG-PS: A single-arm prospective study

Autor(es)

Cunha, Mateus Trinconi ; de Souza Borges, Ana Paula ; Jardim, Vinicius Carvalho ; Fujita, Andre ; de Castro Jr, Gilberto

• Tipo de documento: Artigo Científico
• Fonte: CANCER MEDICINE; v. N/A, p. 11-pg., 2022-09-26.

Resumo

Background Patients with advanced non-small cell lung cancer (NSCLC) are a heterogeneous population with short lifespan. We aimed to develop methods to better differentiate patients whose survival was >90 days. Methods We evaluated 83 characteristics of 106 treatment-naive, stage IV NSCLC patients with Eastern Cooperative Oncology Group Performance Status (ECOG-PS) >1. Automated machine learning was used to select a model and optimize hyperparameters. 100-fold bootstrapping was performed for dimensionality reduction for a second ("lite") model. Performance was measured by C-statistic and accuracy metrics in an out-of-sample validation cohort. The "lite" model was validated on a second independent, prospective cohort (N = 42). Network analysis (NA) was performed to evaluate the differences in centrality and connectivity of features. Results The selected method was ExtraTrees Classifier, with C-statistic of 0.82 (p < 0.01) and accuracy of 0.81 (p = 0.01). The "lite" model had 16 variables and obtained C-statistic of 0.84 (p < 0.01) and accuracy of 0.75 (p = 0.039) in the first cohort, and C-statistic of 0.706 (p < 0.01) and accuracy of 0.714 (p < 0.01) in the second cohort. The networks of patients with lower survival were more interconnected. Features related to cachexia, inflammation, and quality of life had statistically different prestige scores in NA. Conclusions Machine learning can assist in the prognostic evaluation of advanced NSCLC. The model generated with a reduced number of features showed high accessibility and reasonable metrics. Features related to quality of life, cachexia, and performance status had increased correlation and importance scores, suggesting that they play a role at later disease stages, in line with the biological rationale already described. (AU)

• Processo FAPESP: 15/22814-5 - Câncer e coração: novos paradigmas de diagnóstico e tratamento
• Beneficiário: Carlos Eduardo Negrão
• Modalidade de apoio: Auxílio à Pesquisa - Temático
• Processo FAPESP: 16/20187-6 - Caquexia em pacientes com carcinoma pulmonar de células não pequenas: influência da aptidão física sobre o prognóstico
• Beneficiário: Willian das Neves Silva
• Modalidade de apoio: Bolsas no Brasil - Doutorado
• Processo FAPESP: 18/21934-5 - Estatística de redes: teoria, métodos e aplicações
• Beneficiário: André Fujita
• Modalidade de apoio: Auxílio à Pesquisa - Temático
• Processo FAPESP: 19/03615-2 - Difusão em redes dirigidas para o estudo do câncer de mama triplo-negativo
• Beneficiário: Vinícius Jardim Carvalho
• Modalidade de apoio: Bolsas no Brasil - Doutorado